132 related articles for article (PubMed ID: 26037713)
1. Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.
Kobayashi T; Aikata H; Hatooka M; Morio K; Morio R; Kan H; Fujino H; Fukuhara T; Masaki K; Ohno A; Naeshiro N; Nakahara T; Honda Y; Murakami E; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Hyogo H; Takahashi S; Chayama K
Eur Radiol; 2015 Nov; 25(11):3272-81. PubMed ID: 26037713
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm.
Mita K; Kim SR; Kudo M; Imoto S; Nakajima T; Ando K; Fukuda K; Matsuoka T; Maekawa Y; Hayashi Y
World J Gastroenterol; 2010 Sep; 16(33):4187-92. PubMed ID: 20806437
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound in the detection of intrahepatic lesion.
Li J; Ye X; Wang J; Yuan G; He S
Medicine (Baltimore); 2022 Sep; 101(36):e30482. PubMed ID: 36086711
[TBL] [Abstract][Full Text] [Related]
4. Differences in the Diagnosis and Treatment of Patients with Early-Stage Hepatocellular Liver Cancer by Multi-Row Spiral CTMDCT and Gd-EOB-DTPA-Enhanced MRI.
Wang K; Jin X; Zhou J; Wang Z; Zhang X
Altern Ther Health Med; 2024 Jan; 30(1):31-35. PubMed ID: 37773658
[TBL] [Abstract][Full Text] [Related]
5. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with serum markers in at-risk patients with hepatitis B virus.
Han D; Li Y; He X; Zhang J; Zhou Y; Zhang J; Zhang L
Quant Imaging Med Surg; 2023 Oct; 13(10):7156-7169. PubMed ID: 37869332
[TBL] [Abstract][Full Text] [Related]
6. Characterization of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI via contrast-enhanced ultrasound using perfluorobutane.
Bae JS; Lee JY; Suh KS; Hong SK; Yoon JH; Kim YJ; Yu SJ; Lee JH; Cho EJ; Lee YB; Han JK
Abdom Radiol (NY); 2023 Jul; 48(7):2321-2330. PubMed ID: 37097451
[TBL] [Abstract][Full Text] [Related]
7. Hepatobiliary-phase gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid MRI for pretreatment prediction of efficacy-to-standard-therapies based on Barcelona Clinic Liver Cancer algorithm: an up-to-date review.
Minamiguchi K; Irizato M; Uchiyama T; Taiji R; Nishiofuku H; Marugami N; Tanaka T
Eur Radiol; 2023 Dec; 33(12):8764-8775. PubMed ID: 37470828
[TBL] [Abstract][Full Text] [Related]
8. Prediction of vessels encapsulating tumor clusters pattern and prognosis of hepatocellular carcinoma based on preoperative gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic acid magnetic resonance imaging.
Wang M; Cao L; Wang Y; Huang H; Cao S; Tian X; Lei J
J Gastrointest Surg; 2024 Apr; 28(4):442-450. PubMed ID: 38583894
[TBL] [Abstract][Full Text] [Related]
9. Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma.
Ban JY; Kang TW; Jeong WK; Lee MW; Park B; Song KD
PLoS One; 2024; 19(5):e0304352. PubMed ID: 38787832
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis.
Wu Y; Xia C; Chen J; Qin Q; Ye Z; Song B
Abdom Radiol (NY); 2024 Jan; 49(1):34-48. PubMed ID: 37823913
[TBL] [Abstract][Full Text] [Related]
11. On-Site Diagnostic Ability of CEUS/CT/MRI for Hepatocellular Carcinoma (2019-2022): A Multicenter Study.
Yang Q; Zheng R; Zhou J; Tang L; Zhang R; Jiang T; Jing X; Liao J; Cheng W; Zhao C; Liu C; Dietrich CF; Cui X; Cai W; Wu J; Yu F; Cheng Z; Liu F; Han Z; Yu X; Yu J; Liang P
J Ultrasound Med; 2023 Dec; 42(12):2825-2838. PubMed ID: 37713625
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis.
Zhou S; Wang S; Xiang J; Han Z; Wang W; Zhang S; Opara NC; Ju S; Cui Y; Wang YC
Abdom Radiol (NY); 2024 Feb; 49(2):471-483. PubMed ID: 38200213
[TBL] [Abstract][Full Text] [Related]
13. Effect of magnetic resonance imaging in liver metastases.
Huang XL; Wang XD; Gong ZM; Zheng YF; Mao JX
World J Gastroenterol; 2024 Jan; 30(1):112-114. PubMed ID: 38293328
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic efficacy of contrast-enhanced ultrasound for breast lesions of different sizes: a comparative study with magnetic resonance imaging.
Li C; Yao M; Shao S; Li X; Li G; Wu R
Br J Radiol; 2020 Jun; 93(1110):20190932. PubMed ID: 32216631
[TBL] [Abstract][Full Text] [Related]
15. Pre-operative enhanced magnetic resonance imaging combined with clinical features predict early recurrence of hepatocellular carcinoma after radical resection.
Chen JP; Yang RH; Zhang TH; Liao LA; Guan YT; Dai HY
World J Gastrointest Oncol; 2024 Apr; 16(4):1192-1203. PubMed ID: 38660657
[TBL] [Abstract][Full Text] [Related]
16. Clear cell hepatocellular carcinoma: Gd-EOB-DTPA-enhanced MR imaging features and prognosis.
Song M; Tao Y; He K; Du M; Guo L; Hu C; Zhang W
Abdom Radiol (NY); 2024 Apr; ():. PubMed ID: 38557768
[TBL] [Abstract][Full Text] [Related]
17. Multifocal hepatic small vessel neoplasm: Imaging features at Gd-EOB-DTPA-enhanced MRI.
Simon G; Lebail B; Calame P
Diagn Interv Imaging; 2023 Nov; 104(11):562-563. PubMed ID: 37758601
[No Abstract] [Full Text] [Related]
18. Additional nodules detected using EOB-MRI in patients with resectable single hepatocellular carcinoma: an implication for active treatment strategy.
Kim NR; Rho SY; Navarro J; An C; Han DH; Choi JS; Kim MJ; Choi GH
J Liver Cancer; 2024 Mar; 24(1):92-101. PubMed ID: 38351675
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the diagnostic value of contrast-enhanced ultrasound combined with conventional ultrasound versus magnetic resonance imaging in malignant non-mass breast lesions.
Zhang F; Wang J; Jin L; Jia C; Shi Q; Wu R
Br J Radiol; 2023 Oct; 96(1150):20220880. PubMed ID: 37393540
[TBL] [Abstract][Full Text] [Related]
20. A Prospective Assessment of the Diagnostic Value of Contrast-Enhanced Ultrasound, Dynamic Computed Tomography and Magnetic Resonance Imaging for Patients with Small Liver Tumors.
Hsiao CY; Chen PD; Huang KW
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31480576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
